ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0326

Gender Disparities in Clinical Outcomes Among Older Adults with Knee Osteoarthritis: A Retrospective Cohort Study

Kinga Grzybowski1, Ahmer Khan2, Samuel Bonomo3 and Arthur Lau4, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Montgomery Hospital, East Norriton, PA, 4Jefferson Einstein Hospital, Maple Glen, PA

Meeting: ACR Convergence 2025

Keywords: Disparities, gender, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) is the most common type of arthritis which classically affects multiple joints, mainly the knees. About 595 million people worldwide suffer from OA which affects older individuals after the age of 50; females more frequently affected than males. The reason for the increased risk in females is suspected to be multifactorial and possibly related to genetics and environment. Many studies have found that women suffer from more severe disease compared to men. An observational, retrospective cohort study was conducted using the TriNetX database, which uses electronic health records from over 140 global collaborative networks, to explore gender differences in the diagnostic evaluation, treatment, and outcomes in patients with OA of the knees.

Methods: Inclusion criteria were limited to patients above the age of 65, assigned the ICD-10 code M17 for the diagnosis of OA of the knee. Individuals with RA, osteoporosis, gout, FM, polymyalgia rheumatica, AS and patients on steroids were excluded. Two cohorts were studied: females and males over the age of 65. The index event was defined as the initial appearance of the diagnosis of OA of the knee. Propensity matching was used for age, race/ethnicity and other comorbidities at the time of the index event. The outcomes evaluated included falls, fractures, depression, anxiety, PCP Visits, hospitalizations, mortality, chronic pain, opioid use, sleep disturbances, and visits to skilled nursing facilities (SNF Visits). Patients who experienced any of these outcomes prior to the index event were excluded and both risk and risk ratio calculations were measured.

Results: The dataset included 354,678 males, and 521,319 females. After propensity matching the average age was 70. Most males and females were White, of unknown race, or Black/African American. After propensity matching, a total of 219,227 patients were excluded from both groups and the outcomes were calculated. Analysis showed a statistically significant difference for falls (RR 1.141, 95% CI 1.105-1.178, P < 0.0001), fractures (RR 1.349, 95% CI 1.29-1.41, P < 0.0001), depression (RR 1.409, 95% CI 1.369-1.451, P < 0.0001), anxiety (RR 1.507, 95% CI 1.469-1.546, P < 0.0001), and SNF visits (RR 1.226, 95% CI 1.054-1.426, P 0.0080) in females. Additionally, PCP visits (RR 0.972, 95% CI 0.952-0.992, P 0.0074), hospitalizations (RR 0.645, 95% CI 0.539-0.771, P < 0.0001), mortality (RR 0.855, 95% CI 0.819-0.893, P < 0.0001), opioid use (RR 0.648, 95% CI 0.554-0.76, P < 0.0001), and sleep disorders (RR 0.821, 95% CI 0.803-0.841, P < 0.0001) were determined to be statistically significant in males.

Conclusion: The study shows that females with OA are at higher risk for falls, fractures, depression, anxiety, and SNF visits. Men with OA are more likely to face sleep disorders, seek PCP visits, require more hospitalizations, have a higher mortality, and are more likely to be prescribed opioids, indicating that both genders face different consequences of OA, and that gender discrepancies exist. Additional research should be conducted specifically focusing on gender differences in osteoarthritis to explore potential contributive or causative factors that may explain these findings.

Supporting image 1Table 1: Baseline Characteristics of Both Cohorts Before (Left) and After (Right) Propensity Matching

Supporting image 2Table 2: Differences in Diagnosis, Treatment, and Clinical Outcomes of Both Cohorts


Disclosures: K. Grzybowski: None; A. Khan: None; S. Bonomo: None; A. Lau: None.

To cite this abstract in AMA style:

Grzybowski K, Khan A, Bonomo S, Lau A. Gender Disparities in Clinical Outcomes Among Older Adults with Knee Osteoarthritis: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gender-disparities-in-clinical-outcomes-among-older-adults-with-knee-osteoarthritis-a-retrospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-disparities-in-clinical-outcomes-among-older-adults-with-knee-osteoarthritis-a-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology